Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
COVID-19 vaccines
COVID-19 vaccines
Page 23 of 95
Newsletters
Shareholders are putting more pressure on companies over environmental and social issues
By
David Meyer
and
Alan Murray
February 15, 2022
Politics
Canada’s ‘Freedom Convoy’ protesters block 2 more bridges to the U.S. in defiance of Trudeau’s new Emergencies Act powers
By
Jen Skerritt
,
Robert Tuttle
and
Bloomberg
February 15, 2022
Here’s how much the ‘Freedom Convoy’ has cost the U.S. and Canada
By
Megan Leonhardt
February 14, 2022
International
Police cleared Canada’s ‘Freedom Convoy’ protesters from the Ambassador Bridge, but truckers in Ottawa won’t budge
By
Eamon Barrett
February 14, 2022
Newsletters
Sometimes Super Bowl ads show someone has too much money to burn
By
David Meyer
and
Alan Murray
February 14, 2022
International
Singapore is the latest country to approve Novavax’s COVID vaccine while the U.S. reviews application
By
Grady McGregor
February 14, 2022
Health
Is the COVID pandemic getting less deadly? The gap between cases and deaths is widening
By
Tom Randall
and
Bloomberg
February 14, 2022
Health
The program meant to help pregnant people safely find prescriptions to take has stalled
By
Kat Eschner
February 13, 2022
Health
From New York to the Netherlands, the (western) world is moving on from Omicron. Here’s where the big rollback is happening
By
Tristan Bove
February 12, 2022
Leadership
Pfizer’s CEO, a former veterinarian, used a high-risk strategy to make vaccine history
By
Carmela Chirinos
February 12, 2022
Health
FDA postpones meeting on Pfizer COVID shot for kids under 5
By
Fiona Rutherford
and
Bloomberg
February 11, 2022
Newsletters
Why engine maker Cummins is lobbying President Biden for new climate legislation
By
David Meyer
and
Alan Murray
February 11, 2022
China likely needs mRNA vaccines to reopen. Omicron boosters are a better bet
By
Grady McGregor
February 11, 2022
International
Why Canada’s ‘Freedom Convoy’ truckers, whose protest has blocked trade with the U.S., can’t just be towed away
By
Eamon Barrett
February 10, 2022
Health
CVS expects demand for COVID-19 tests and vaccines to fade as cases fall
By
Angelica Peebles
and
Bloomberg
February 9, 2022
Most Popular
Economy
Ford workers told their CEO 'none of the young people want to work here.' So Jim Farley took a page out of the...
By
Sasha Rogelberg
Economy
National debt crisis will be averted by governments 'mobilizing and encouraging' private wealth to fill budget holes,...
By
Eleanor Pringle
C-Suite
What the CEO of the world's largest data center company—with 273 locations in 36 countries—predicts will drive the...
By
Diane Brady
and
Sharon Goldman